Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) shares rose 4.7% during trading on Monday . The stock traded as high as $22.45 and last traded at $22.38. Approximately 76,700 shares changed hands during mid-day trading, a decline of 95% from the average daily volume of 1,433,598 shares. The stock had previously closed at $21.38. […]
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) shares were down 6.6% during mid-day trading on Thursday . The stock traded as low as $20.84 and last traded at $21.23. Approximately 468,916 shares changed hands during trading, a decline of 67% from the average daily volume of 1,435,909 shares. The stock had previously closed at […]
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 14,320,000 shares, an increase of 9.2% from the February 29th total of 13,110,000 shares. Based on an average daily volume of 1,420,000 shares, […]
Shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) have earned an average recommendation of “Hold” from the thirteen research firms that are presently covering the company, Marketbeat Ratings reports. Eight equities research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average […]
Beam Therapeutics (NASDAQ:BEAM – Get Free Report)‘s stock had its “outperform” rating restated by investment analysts at BMO Capital Markets in a research report issued on Wednesday, Benzinga reports. They presently have a $57.00 target price on the stock. BMO Capital Markets’ target price suggests a potential upside of 68.29% from the stock’s previous close. […]